The Neurology Department of West China Hospital, Sichuan University, Chengdu, China.
The Neurology Department of West China Hospital, Sichuan University, Chengdu, China.
J Stroke Cerebrovasc Dis. 2024 Sep;33(9):107855. doi: 10.1016/j.jstrokecerebrovasdis.2024.107855. Epub 2024 Jul 11.
Stroke is a leading cause of disability and mortality globally. This study aimed to develop a prognostic nomogram based on neutrophil-to-albumin ratio (NAR) and collateral status in acute ischemic stroke (AIS) patients with anterior large vessel occlusion (LVO).
MATERIAL & METHOD: 590 AIS patients with LVO assessed for regional leptomeningeal collateral (rLMC) were retrospectively enrolled, and randomly divided into a training set (n = 414) and a testing set (n = 176). Unfavorable functional outcome was defined as a modified Rankin scale (mRS) score of 3 to 6 at 3 months. We assessed the accuracy and clinical utility of the nomogram using calibration plots, area under the curve (AUC), decision curve analysis (DCA), net reclassification index (NRI), and integrated discrimination improvement (IDI).
Both NAR and rLMC were independently associated with unfavorable outcome at 3 months (OR=8.96, p=0.0341; OR=0.89, p=0.0002, respectively). The developed nomogram (akaike information criterion (AIC)=398.77), which included NAR, rLMC and other factors, showed good performance (the AUC for the development and validation cohorts was 0.848 and 0.840 respectively) and improved the predictive value compared to a model without NAR and rLMC, according to an overall NRI of 3.27% (p=0.2401), overall IDI of 3.27% (p=0.2414), and a higher AUC (0.848 vs 0.831).
NAR can serve as an independent predictor in AIS patients with anterior LVO, and the nomogram incorporating NAR and rLMC is reliable in predicting unfavorable outcome. Further studies with larger sample sizes are needed to validate and extend these findings.
卒中是全球范围内导致残疾和死亡的主要原因。本研究旨在为前循环大血管闭塞(LVO)的急性缺血性卒中(AIS)患者建立基于中性粒细胞与白蛋白比值(NAR)和侧支状态的预后列线图。
回顾性纳入 590 例 LVO 评估区域软脑膜侧支循环(rLMC)的 AIS 患者,随机分为训练集(n=414)和测试集(n=176)。3 个月时改良 Rankin 量表(mRS)评分 3-6 分定义为不良功能结局。我们通过校准图、曲线下面积(AUC)、决策曲线分析(DCA)、净重新分类指数(NRI)和综合判别改善(IDI)评估列线图的准确性和临床实用性。
NAR 和 rLMC 均与 3 个月时的不良结局独立相关(OR=8.96,p=0.0341;OR=0.89,p=0.0002)。该列线图(akaike 信息准则(AIC)=398.77),包含 NAR、rLMC 和其他因素,表现出良好的性能(开发和验证队列的 AUC 分别为 0.848 和 0.840),与不包含 NAR 和 rLMC 的模型相比,提高了预测价值,总 NRI 为 3.27%(p=0.2401),总 IDI 为 3.27%(p=0.2414),AUC 更高(0.848 比 0.831)。
NAR 可作为前循环 LVO 的 AIS 患者的独立预测因子,包含 NAR 和 rLMC 的列线图在预测不良结局方面可靠。需要更大样本量的进一步研究来验证和扩展这些发现。